Talea Group S.p.a. · MIL:TALEA
Talea — Farmaè — Stifel Virtual Roadshow (November 2022)
28 slides from Talea's conference presentation, Nov 16, 2022
Slide 1: Roadshow Stifel
Roadshow Stifel 16 November 2022
Slide 2: The first true Multi-Channel online player in Europe in the reference Macro Sector
The first true Multi-Channel online player in Europe in the reference Macro Sector
Slide 3: A unique history of growth
A unique history of growth The growth speed is the main driver for a successfull positioning Beautyè AmicaFarmacia Listed on the Launch acquisition Opening of offline AIM Market 2020 stores in Tuscany €65.5m 2018 2016 €24,9m €7.6m 2022 2014 2021 2019 2019 €85.9m Revenues 2017 €37.5m 2015 €13.3m New
Slide 4: The first true Multi-Channel online player in Europe in the reference Macro Sector
The first true Multi-Channel online player in Europe in the reference Macro Sector Health, Wellness & Pet Farmaè Group is the undisputed leader in Italy with its online platforms: www.farmae.it, Beauty www.amicafarmacia.com, www.farmaeurope.eu. The Group operates in the Beauty market (professional s
Slide 5: A results-oriented agency
A results-oriented agency Thanks to an innovative business model in the field of online communication and marketing, Valnan is a point of reference for Italian SMEs of different sectors Valnan Communications is an Online Communication and Marketing agency that offers its clients a unique mix of serv
Slide 6: From Data Economy to Media
From Data Economy to Media 9M 2022 Co-marketing Revenues at € 3.1m*, +29% YoY Thanks to the knowledge and transparency of the reading of millions of data Farmaè has become a reference media for the main industries in the sector Farmaè develops partnerships with the main industrial companies in the s
Slide 7: Health and Wellness Market
Health and Wellness Market
Slide 8: Farmaè Group is the undisputed leader on the Italian market
Farmaè Group is the undisputed leader on the Italian market Top 5 players represent the 46% Traffic Share leadership of Market Revenues Farmaè + AmicaFarmacia + Farmaeurope at 59% 125% 97% 99% 100% 100% 92% 82% 75% 75% 62% 55% 50% 46% 25% 0% Top5 Top15 Top 50 Top Other Small Source: IQVIA 2020 Sourc
Slide 9: Italian enlarged competitive scenario
Italian enlarged competitive scenario Generalists and specialized portals must also be considered in the competitive scenario Pharmacies, parapharmacies Generalist portals, Specialized portals and chains marketplaces 9
Slide 10: European Pharmacy Trend
European Pharmacy Trend In other European countries, where prescription drugs are also sold online, the share of online reaches 18%, as in Germany Legislation 2,5 bn€ 398 mln€ 10
Slide 11: Financials
Financials +FARMAEGROUP
Slide 12: Integration with acquired businesses and economies of scale boost revenues and margins
Integration with acquired businesses and economies of scale boost revenues and margins ▪ Consolidated revenues: € 52.8 million, +34.5% YoY driven by ▪ 3Q2022 Consolidated revenues*: the integration of AmicaFarmacia € 28.4 million, +58.3% YoY +17.7% YoY on a like for like basis ▪ Co-marketing: € 2.1
Slide 13: The first online player in Italy in the Healthcare, Beauty and Wellness sector
The first online player in Italy in the Healthcare, Beauty and Wellness sector 100,000 +17% SKUs Conversion Rate 8,496,000 1,690,000 Products sold Online Orders KPI Performance 9M2022 13 13
Slide 14: Update on recent KPIs
Update on recent KPIs Orders (m)* Product sold (m)* CAGR CAGR 2016-2021 2016-2021 + 103.1% +86.7% Site Visits (m) Conversion Rate (%) CAGR 2016-2021 +21.3% CAGR 2016-2021 + 68.2% * 9M2022 KPIs are unaudited 14
Slide 15: Main Financial Highlights
Main Financial Highlights Revenues (€/m)** Marketing & Distribution expenses (€/m) Italian GAAP IFRS EBITDA (€/m) Net Profit (€/m) +45.3% Italian GAAP IFRS Italian GAAP IFRS *It should be noted that the scope of consolidation as at 30 June 2022 includes Farmaè S.p.A. (with the results of the Farmaè,
Slide 16: Profitability improves
Profitability improves 1H2022 vs. 1H2021 Revenues breakdown €/mln 1H2022 1H2021 YOY Sales 52.8 39.3 34.5% Gross Margin 17.1 12.5 4.6 Gross Margin 32.4% 31.8% 0.6% Selling and distribution as -23.7% -24.9% 1.3% percentage of sales Administrative costs as -7.0% -5.6% -1.4% percentage of sales Other op
Slide 17: Proven execution in integrating acquired companies or brands
Proven execution in integrating acquired companies or brands +5.2% YoY Online Platform € 77.2m € 81.2m www.farmae.it www.amicafarmacia.com 9M2021 Consolidated 9M2022 Consolidated www.farmaeurope.eu Revenues Revenues* ✓ One single entity Farmaè S.p.A.; Synergies ✓ A unique phurchase department with b
Slide 18: Solid Balance Sheet
Solid Balance Sheet Net Working Capital (€/m) Net Financial Position (€/m) 14.1 19.7 3.3 Italian GAAP IFRS 18
Slide 19: Strategy and Outlook
Strategy and Outlook +FARMAEGROUP
Slide 20: Group strategy
Group strategy Achieving a Profitable Growth People Commercial Services Tech & Marketing Organic growth and M&A Improvement of Logistics Capacity Value of the person is key Evolution of technological Leadership consolidation on the Shipping in 24 hours platforms Continued training of employees onlin
Slide 21: ESG strategy
ESG strategy THE PLAN. In 2021 we formulated our strategic sustainability plan confirming our commitment to sustainable growth and the importance we attach to environmental and social responsibility within the Group's business model. The Plan provides for the identification, through the materiality
Slide 22: Appendix
Appendix
Slide 23: Governance
Governance BOARD OF DIRECTORS STOCK FIGURES Outstanding shares 6,846,270 Market EGM Riccardo Iacometti post-IPO Chairman & CEO Free Float 28.04% Date IPO July 29, 2019 Marco Di Filippo Market Cap (30/09/2022) € 67.26m Alberto Maglione Giuseppe Cannarozzi Issue Price (€) € 7.50 Director General Manag
Slide 24: Technological development to support business
Technological development to support business A company capable of transforming itself into a Tech Company. Constant introduction of technological innovation both in terms of software solutions for business rather than digital platforms to take full advantage of the opportunities of Web 4.0, making
Slide 25: The purchasing experience also through the service
The purchasing experience also through the service The development of the logistic capacity to improve and accelerate the main service lever: delivery Advanced Logistic Hubs to efficiently serve customers Farmaè 5,000 sqm Automated logistics hub located in New warehouse to support growth Migliarino
Slide 26: ESG timeline
ESG timeline 2021 2022 2023 2025 2027 Establishment of the Emission Calculation First Sustainability Farmaè Carbon Ttarget “ Net Zero ESG Function Scope 1 and 2 Report Neutral Scope Emission” Scope 1,2 and 3 1,2 and 3 to 2050 as for climate objectives Farmaè Carbon Investment plan for Neutral emissi
Slide 27: Disclaimer
Disclaimer “This Presentation contains certain forward-looking statements. Forward-looking statements concern future circumstances and results and other statements that are not historical facts, sometimes identified by the words "believes," "expects," "predicts," "intends," "projects," "plans," "est
Slide 28: Thank You
Thank You +FARMAECROUP